Semaglutide 12mg Cartridge

Please note: This item is shipped directly from the manufacturer. Delivery may take slightly longer than usual, with an estimated turnaround time of 5 to 7 working days.

Novo-Lela Semaglutide 12mg Cartridge contains a higher concentration of Semaglutide for subcutaneous administration. Semaglutide is a GLP-1 receptor agonist that enhances insulin secretion, suppresses glucagon release, and delays gastric emptying to help regulate blood glucose levels and support weight loss.

The 12mg cartridge is compatible with appropriate injection pens and provides the same therapeutic profile as lower-dose cartridges, allowing for flexible dosing in patients requiring higher maintenance levels for diabetes or weight management.

Benefits of Semaglutide:

• Blood Sugar Regulation: Improves insulin secretion and reduces glucagon levels in a glucose-dependent manner.

• Weight Loss Support: Reduces appetite and slows gastric emptying to support weight reduction.

• Cardiovascular Protection: Associated with a lower risk of major cardiovascular events in type 2 diabetes.

Dosage Instructions:

Administer Novo-Lela Semaglutide 12mg Cartridge subcutaneously using an appropriate insulin-like syringe that is supplied.

• Type 2 Diabetes: Begin with 0.25 mg once weekly, titrate to 0.5 mg, and then 1.0 mg or more based on patient response.

• Weight Management: Higher doses, up to 2.4 mg weekly, may be prescribed as part of a structured treatment plan.

• Injections should be administered on the same day each week, with or without food.

Always adhere to the dosage schedule prescribed by your healthcare provider.

Side Effects:

Potential side effects include:

• Gastrointestinal symptoms (nausea, vomiting, diarrhea)

• Hypoglycemia when combined with other medications

• Injection site reactions

• Rare pancreatitis

• Gallbladder-related events in long-term use

Half-life:

Semaglutide’s half-life is approximately one week, allowing for convenient once-weekly dosing.

In summary, Novo-Lela Semaglutide 12mg Cartridge provides a higher-strength GLP-1 receptor agonist option for effective glycaemic control and weight management. It delivers the same clinical benefits as other formulations while allowing flexible dosing for intensified therapy.